目的：探讨沐舒坦合并病毒唑氧气雾化吸入治疗小儿支气管肺炎的临床疗效。方法回顾分析300例沐舒坦合并病毒唑氧气雾化吸入治疗小儿支气管肺炎病例资料（观察组），并与同期295例采用病毒唑雾化吸入治疗小儿支气管肺炎病例资料（对照组）对比分析疗效。结果观察组（94.33%）在缓解哮喘等临床治疗效果优于对照组（69.49%），两组具有统计学差异性意义（P ＜0.05）。结论沐舒坦合并病毒唑氧气雾化吸入治疗小儿支气管肺炎临床效果显著、安全、有效，值得临床广泛推广应用。%Objective to investigate the ambroxol combined with ribavirin oxygen inhalation in treatment of children with bronchial pneumonia patients. Methods retrospective analysis of 300 cases of ambroxol combined with ribavirin oxygen inhalation in treatment of bronchial pneumonia in children patients (observation group), and compared with 295 cases with inhalation of Virazole in treatment of children with bronchial pneumonia cases (control group) compared the effect. Results the observation group (94.33%) in alleviating asthma and clinical therapeutic effect is better than that of control group (69.49%), two groups have statistical significance difference (P < 0.05). Conclusion Massage comfortable with ribavirin oxygen atomization inhalation treatment of children with bronchial pneumonia clinical effect is remarkable, safe, effective, is worth to be widely applied clinically.
展开▼
